Physicochemical aspects of drug delivery and release from polymer-based colloids

Current Opinion in Colloid and Interface Science

Volumn 5, Issue 1-2, 2000, Pages 132-143

  Yang, Lin ^a   Alexandridis, Paschalis ^a  

^a State University of New York ^*  (United States)

Author keywords

Block copolymers; Colloid; DNA; Drug carriers; Liposome; Micelle; Nanoparticle; Polymer based systems; Protein; Release

Indexed keywords

ALUMINUM HYDROXIDE; COPOLYMER; DNA; DRUG CARRIER; LIPOSOME; MACROGOL; NANOPARTICLE; POLYMER; PROTEIN;

BIOCOMPATIBILITY; CHEMICAL MODIFICATION; COLLOID; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; LIGAND BINDING; MICELLE; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; REVIEW;

EID: 0033824361     PISSN: 13590294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-0294(00)00046-7     Document Type: Article

References (108)

1. Polymers for controlled parenteral delivery of peptides and proteins
2. Polymers in drug delivery
3. Use of nonionic block copolymers in vaccines and therapeutics
4. Polymeric systems for controlled drug release
5. Phase-transition polymers for drug delivery
6. Cationic polymer based gene delivery systems
7. Poly(ethylenimine) and its role in gene delivery
8. Gene-delivery systems using cationic polymers
9. Non-viral peptide-based approaches to gene delivery
10. Microemulsions: An overview and pharmaceutical applications
11. Diblock copolymer nanoparticles for drug delivery
12. Solvent-regulated ordering in block copolymers
13. Polymer micelles - An example of self-assembling polymers
14. Poly(ethylene oxide)/poly(propylene oxide) block copolymer surfactants
15. Nano-engineering block copolymer aggregates for drug delivery
16. Polymeric micelles - A new generation of colloidal drug carriers
17. Methoxy poly(ethylene glycol)/(-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization
18. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size
19. Development of copolymers of poly(D, L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel
20. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles
21. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments
22. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells
23. Amphiphilic poly(Ala)-b-poly(Sar) microspheres loaded with hydrophobic drug
24. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer
25. Novel polyion complex micelles entrapping enzyme molecules in the core: Preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium
26. Polymeric micelles as drug delivery systems: A reactive polymeric micelle carrying aldehyde groups
27. Surface charge modulation of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles: Conjugation of charged peptides
28. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs
29. Adriamycin release from flower-type polymeric micelle based on star-block copolymer composed of poly(γ-benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part
30. Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery
31. Shell cross-linked polymer micelles: Stabilized assemblies with great versatility and potential
32. SANS Investigation of polyether block copolymer micelle structure in mixed solvents of water and formamide, ethanol, or glycerol
33. Multiple physiological functions for multidrug transporter P-glycoprotein?
34. Effects of Pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells
35. Inhibition of multidrug resistance-associated protein (MRP) functional activity with Pluronic block copolymers
36. Stealth liposomes
37. Preparation and characterization of liposomes as therapeutic delivery systems: A review
38. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits
39. The potential of liposomes in oral drug delivery
40. Polymerization of preformed self-organized assemblies
41. In vitro evaluation of polymerized liposomes as an oral drug delivery system
42. Polymersomes: Tough vesicles made from di-block copolymers
43. Polymer-coated long-circulating microparticulate pharmaceuticals
44. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel
45. Effect of PEO-PPO-PEO triblock copolymers on structure and stability of phosphatidylcholine liposomes
46. Effects of incorporation of various amphiphiles into recipient liposome membranes on inter-membrane protein transfer
47. Interaction of a lipid-membrane destabilizing enzyme with PEG-liposomes
48. Influence of lipopolymer concentration in liposome degradation and blood clearance
49. In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions
50. Synthesis of a novel lipopeptide with α-melanocyte-stimulating hormone peptide ligand and its effect on liposome stability
51. Improvement of temperature-sensitivity of poly(N-isopropylacrylamide)-modified liposomes
52. Thermosensitive liposomal taxol formulation: Heat-mediated targeted drug delivery in murine melanoma
53. Fast laser-induced solute release from liposomes sensitized with photochromic lipid: Effects of temperature, lipid host, and sensitizer concentration
54. 2+ release from diplasmenylcholine liposomes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes
55. Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood
56. Injectable biodegradable microspheres for vaccine delivery
57. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues
58. Nanoparticulate drug carrier technology
59. Nanoparticles: Preparation and characterization
60. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres
61. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres
62. Sustained delivery of proteins for novel therapeutic products
63. Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods
64. PLGA microspheres containing plasmid DNA: Preservation of super-coiled DNA via cryopreparation and carbohydrate stabilization
65. Why does PEG 400 co-encapsulation improve NGF stability and release from PLAG biodegradable microspheres?
66. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol
67. Porcine insulin biodegradable polyester microspheres: Stability and in vitro release characteristics
68. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres
69. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide)
70. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: Applications in cancer drug delivery and imaging
71. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS
72. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: The surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments
73. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition
74. Influence of shaking and surfactants on the release of BSA from PLGA microspheres
75. Sustained-release interleukin-12 microspheres in the treatment of cancer
76. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect
77. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method
78. Modulated release of IdUrd from poly(D,L-lactide-co-glycolide) microspheres by addition of poly(D,L-lactide) oligomers
79. A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres
80. The control of protein release from poly(DL-lactide-co-glycolide) microparticle by variation of the external aqueous phase surfactant in the water-in oil-in water method
81. Sustained release of human growth hormone from PLGA solution depots
82. Hydrogels
83. Hydrogels and drug delivery
84. Kinetic modeling for macromolecule loading into crosslinked polyacrylamide hydrogel matrix by swelling
85. Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein
86. Applications of polyoxyalkylene block copolymer surfactants
87. Amphiphilic copolymers and their applications
88. Biodegradable block copolymers as injectable drug-delivery systems
89. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers
90. Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel
91. Transdermal photopolymerization for minimally invasive implantation
92. Bioadhesive and phase-change polymers for ocular drug delivery
93. Phase inversion dynamics of PLGA solutions related to drug delivery
94. Biocompatibility issues of implantable drug delivery systems
95. Poly(ethylene glycol)-containing hydrogels in drug delivery
96. Controlled release of drugs from hydrocolloid embeddings
97. The physics of polymer dissolution: Modeling approaches and experimental behavior
98. HPMC - Matrices for controlled drug delivery: A new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics
99. Mechanism of drug release from poloxamer hydrogels
100. A two-phase model for controlled drug release from biphasic polymer hydrogels
101. Salt effects on the diffusion and release rate of propranolol from Poloxamer 407 gels
102. The effect of liquid crystalline structure on chlorhexidine diacetate release
103. Physicochemical aspects of drug release from poloxamer block copolymer gels
104. Factors determining hydrogel permeability
105. Poly(L-lactic acid)/pluronic blends: Characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrices
106. Mechanisms of solute and drug transport in relaxing, swellable, hydrophilic glassy polymers
107. Interpenetrating networks of Poloxamer copolymers and poly(acrylic acid) as vehicles in controlled drug delivery